Clinical Trials

Drug	Sponsor	Phase	Status
Inhaled Tobramycin	Novartis	II	Complete. Results due Q1 2020
ALX-009	Alaxia	I	Recruiting now
ALX-009	Alaxia	II	Recruiting begins Q3 2020
Inhaled POL7080	Polyphor	I	Recruiting begins Q1 2020
QBW251	Novartis	II	Recruiting begins Q1 2020